Episcleritis and scleritis
Episcleritis and scleritis both cause a red eye, but one is a benign nuisance and the other can destroy the eye and may be the first sign of a life-threatening vasculitis. This lesson explains the anatomy that separates them, the bedside features and phenylephrine test, the systemic associations, and the treatment of scleritis and peripheral ulcerative keratitis.
Three layers of vessels
The white of the eye has three coats over it and in it, each with its own vessels. Outermost is the conjunctiva, a loose mucous membrane with fine, bright red vessels that slide over the globe when the conjunctiva is pushed with a cotton bud. Beneath it lies the episclera, a thin layer of vascular connective tissue between Tenon's capsule and the sclera. The episclera has a superficial plexus of straight, radially arranged vessels and a deep plexus that lies on the sclera and does not move. The sclera itself is dense collagen with very few vessels of its own.
Which plexus is engorged decides the diagnosis. In episcleritis the superficial episcleral plexus is dilated and the eye is bright red or pink. In scleritis the deep plexus is engorged and the sclera is swollen, giving a darker, violet or bluish-red colour, best judged in daylight and not at the slit lamp.
3D atlasThe sclera, with the dark choroid beneath it. When scleritis thins the sclera, the choroid shows through as a blue-grey patch.Episcleritis
Episcleritis is a mild, self-limiting inflammation of the episclera. It mostly affects young and middle-aged adults, women more than men. The eye becomes red over hours, in one sector or diffusely, with mild discomfort or tenderness at most. Vision is normal and there is no discharge. Severe pain should make the examiner doubt the diagnosis.
There are two forms. Simple episcleritis is flat redness that peaks quickly and usually clears within two to three weeks. Nodular episcleritis has a raised, tender nodule that can be moved slightly over the sclera, comes on more gradually and lasts longer. Most cases have no cause. A minority, around a quarter to a third in published series, are associated with a systemic disease such as rheumatoid arthritis, inflammatory bowel disease, vasculitis, gout or atopy, so recurrent cases are worth a systemic enquiry.
Treatment is reassurance. NICE CKS advises that a cold compress or artificial tears may ease symptoms, and that more severe inflammation may need a non-steroidal anti-inflammatory drug such as ibuprofen or steroid eye drops. Steroid drops are kept for specialist use, because they can be followed by rebound redness.
Telling scleritis from episcleritis
The single most useful question is about pain. Scleritis causes a severe, deep, boring pain that builds over days, radiates to the brow, temple, ear or jaw, is worse on eye movement and at night, and wakes the patient from sleep. The globe is tender to touch through the lid.
| Episcleritis | Scleritis | |
|---|---|---|
| Pain | Mild discomfort or none | Severe, boring, radiates to the face and wakes the patient |
| Tenderness of the globe | Slight | Marked |
| Colour | Bright red or pink | Violet or bluish red |
| Vessels | Superficial, radial; move with a cotton bud | Deep, criss-crossing; fixed to the sclera |
| Phenylephrine 10% | Redness blanches | Deep redness persists |
| Vision | Normal | May be reduced |
| Systemic disease | In a minority | In up to half |
| Treatment | Reassurance, lubricants, oral NSAID if needed | Always systemic: oral NSAID, steroid or immunosuppression |
| Outcome | Resolves without damage | Scleral thinning, keratitis, uveitis, glaucoma, loss of the eye |
The phenylephrine test uses the anatomy. Phenylephrine is an alpha-adrenergic agonist that constricts vessels it can reach. One drop of 2.5% blanches the conjunctival vessels; 10% also blanches the superficial episcleral plexus. The deep episcleral plexus is not constricted. If the eye whitens once the drop has acted, the redness was superficial and the diagnosis is episcleritis. If a deep violet flush remains, it is scleritis. Phenylephrine also dilates the pupil and blurs vision, so it is used with care in eyes at risk of angle closure.
Types of scleritis
Scleritis is classified by position and by whether the sclera is dying. Anterior scleritis, in front of the rectus muscle insertions, is much the commoner.
- Diffuse anterior scleritis: widespread redness and scleral swelling. The commonest and least severe form.
- Nodular anterior scleritis: a firm, very tender nodule that is part of the sclera and cannot be moved over it.
- Necrotising scleritis with inflammation: the most severe and most painful. Patches of sclera lose their blood supply and die, leaving thin, translucent sclera through which the blue-black choroid shows. It carries a high rate of visual loss and is associated with increased mortality from the underlying vasculitis.
- Scleromalacia perforans (necrotising scleritis without inflammation): painless. The eye is white, and the sclera slowly thins and becomes avascular, exposing the choroid. It is classically seen in long-standing rheumatoid arthritis.
- Posterior scleritis: inflammation behind the muscle insertions. The front of the eye may look normal, so it is easily missed.
Posterior scleritis presents with deep pain, pain on eye movement and reduced vision. The thickened sclera pushes on the structures inside it, giving choroidal folds, exudative (serous) retinal detachment and optic disc swelling. B-scan ultrasound confirms the diagnosis by showing thickening of the sclera and choroid with fluid in the space beneath Tenon's capsule; where this fluid meets the optic nerve shadow it forms the T sign.
Systemic associations and investigation
Up to half of patients with scleritis have an underlying systemic disease, and scleritis may be its first sign. The sclera is collagen, and the associated diseases are those that inflame connective tissue and small vessels.
- Rheumatoid arthritis: the commonest association.
- Granulomatosis with polyangiitis: the classic cause of necrotising scleritis; ask about nosebleeds, sinusitis and haemoptysis.
- Other vasculitides and connective tissue diseases: polyarteritis nodosa, systemic lupus erythematosus, relapsing polychondritis.
- Seronegative spondyloarthropathies, inflammatory bowel disease and sarcoidosis.
- Infection in a minority: herpes zoster, syphilis, tuberculosis, and bacterial or fungal infection after eye surgery, particularly pterygium surgery with mitomycin C.
Investigation follows the list: full blood count, inflammatory markers, renal function and urinalysis (for vasculitic kidney disease), rheumatoid factor, antinuclear antibody, antineutrophil cytoplasmic antibody (ANCA), syphilis serology and a chest radiograph, with blood pressure. Bilateral scleritis is more often linked to rheumatic disease.
Treating scleritis
The inflamed tissue is deep and poorly vascular, so drops do not reach it in useful concentration. Non-infectious scleritis is treated systemically, on a ladder that depends on severity.
- Oral NSAID, such as flurbiprofen or indometacin, for mild to moderate non-necrotising anterior scleritis.
- Oral corticosteroid, such as prednisolone at about 1 mg/kg a day and then tapered, when NSAIDs fail and from the start in posterior or necrotising disease.
- Pulsed intravenous methylprednisolone for severe, sight-threatening disease.
- Steroid-sparing immunosuppression for disease that relapses as steroid is reduced or is linked to systemic vasculitis: methotrexate or mycophenolate, with cyclophosphamide or rituximab for necrotising disease and granulomatosis with polyangiitis.
The eye physician and the rheumatologist treat the patient together, since controlling the systemic disease controls the eye. Surgery, a scleral patch graft, is needed only for perforation or extreme thinning. Complications of scleritis are peripheral keratitis, uveitis, glaucoma, cataract and, in posterior disease, exudative retinal detachment.
Peripheral ulcerative keratitis
Peripheral ulcerative keratitis (PUK) is the corneal counterpart of necrotising scleritis and often accompanies it. It is a crescent-shaped area of stromal thinning at the edge of the cornea, next to the limbus, with an overlying epithelial defect. The eye is red and painful and the ulcer can perforate (a corneal melt).
The peripheral cornea is vulnerable because it lies beside the limbal blood vessels. Immune complexes lodge there, activate complement and attract neutrophils and macrophages, which release collagenases that dissolve the stroma. Rheumatoid arthritis is the commonest associated disease, followed by granulomatosis with polyangiitis, polyarteritis nodosa and lupus. In established rheumatoid arthritis, PUK or necrotising scleritis signals active systemic vasculitis and carries a raised risk of death from vascular events if untreated.
Treatment is therefore systemic immunosuppression: high-dose corticosteroid with an agent such as cyclophosphamide or rituximab. Local measures support the cornea: intensive preservative-free lubricants, oral doxycycline to inhibit collagenase, and tissue glue or a patch graft for impending perforation. Topical steroid is used with great caution because it can speed the melt. Mooren ulcer is the name for a painful, progressive peripheral ulcerative keratitis with no systemic cause found; it is a diagnosis of exclusion.
Summary
- Episcleritis involves the superficial episcleral plexus, is bright red, mildly uncomfortable and self-limiting with normal vision.
- Scleritis involves the deep plexus and sclera, is violet-red and causes severe boring pain that radiates and wakes the patient.
- Phenylephrine 10% blanches the redness of episcleritis but not the deep redness of scleritis.
- Up to half of patients with scleritis have a systemic disease; rheumatoid arthritis is the commonest and granulomatosis with polyangiitis the classic cause of necrotising disease.
- Necrotising scleritis threatens the eye and is associated with increased mortality.
- Scleromalacia perforans is painless scleral thinning in a white eye, classically in long-standing rheumatoid arthritis.
- Posterior scleritis causes pain, reduced vision, choroidal folds and exudative retinal detachment, and is confirmed on B-scan ultrasound.
- Scleritis is treated systemically: oral NSAID, then oral or intravenous steroid, then immunosuppressants such as methotrexate, cyclophosphamide or rituximab.
- Peripheral ulcerative keratitis is a crescent-shaped melt beside the limbus that signals systemic vasculitis and needs systemic immunosuppression.
Check yourself
Quick recall on this lesson. These are easier than the question bank.
Written for revision. It is not a source of clinical advice, and guidance changes.